Boston Scientific BSX is slated to report fourth-quarter fiscal 2024 results on Feb. 5 before market open. See the Zacks Earnings Calendar to stay ahead of market-making news. For fourth-quarter ...

The company’s third-quarter earnings report for fiscal 2024 showed strong sales growth and adjusted per-share earnings of ...

We recently compiled a list of the 12 Best Fundamental Stocks to Buy Now. In this article, we are going to take a look at ...

The company primarily operates through its MedSurg (endoscopy, urology ... there’s a powerful fundamental story happening with Boston Scientific. Also, EPS is estimated to ramp higher this ...

The stock carries a Zacks Rank #3 (Hold) currently. Boston Scientific’s Endoscopy business within MedSurg is gaining from strong worldwide demand for its broad range of gastrointestinal and ...

Boston Scientific closes the year at historic highs ... includes diagnostic and invasive devices in the fields of Endoscopy, Cardiology, Electrophysiology, and Neuromodulation.

Failed to fetch dynamically imported module: https://uk.finance.yahoo.com/assets/_app/immutable/nodes/98.FiJKC4GV.js ...

Endoscopy capacity should be restored as far as possible ... Competing interests JE served on the clinical advisory board for Lumendi and Boston Scientific and the clinical advisory board and ...

Retired marine scientist and Seaholm resident, Dr Hugh Kirkman, has been named an Officer of the Order of Australia (AO) ...

Buying $1000 In BSX: If an investor had bought $1000 of BSX stock 5 years ago, it would be worth $2,432.39 today based on a ...